Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27917310 | 0.93 | ALDH1A1 (0.36) | HPGDALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL7531109 | 0.93 | ALDH1A1 (0.36) | HPGDALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL2793304 | 0.93 | ALDH1A1 (0.36) | HPGDALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL192669 | 0.93 | ALDH1A1 (0.36) | HPGDALDH1A1MEN1KMT2ASMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL863868 | 0.91 | ALDH1A1 (0.35) | HPGDALDH1A1MEN1KMT2ALMNA | |
| SCHEMBL8681009 | 0.91 | — | — | |
| SCHEMBL200065 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL4957612 | 0.88 | ALDH1A1 (0.33) | ALDH1A1MEN1KMT2AHTTGAA | |
| Propionic Acid SCHEMBL28214094 | 0.87 | FFAR3 (0.42) | HPGDALDH1A1MEN1KMT2ALMNA | |
| Propionic Acid SCHEMBL28044674 | 0.87 | FFAR3 (0.42) | HPGDALDH1A1MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8633225-B2 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2014-01-21 | — | — | US | disclosed |
| EP-2032118-B1 | COSMETIC COMPOSITIONS CONTAINING PIPERIDINIUM COMPOUNDS | BEIERSDORF AG (DE) | 2012-12-19 | — | — | EP | disclosed |
| US-20110044923-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | BEIERSDORF AG (DE) | 2011-02-24 | — | — | US | disclosed |
| US-7851633-B2 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2010-12-14 | — | — | US | disclosed |
| EP-2032118-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | Beiersdorf AG (DE) | 2009-03-11 | — | — | EP | disclosed |
| US-20070292375-A1 | Piperidinium compounds and cosmetic compositions containing them | BEIERSDORF AG (DE) | 2007-12-20 | — | — | US | disclosed |
| WO-2007141289-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | BEIERSDORF AG (DE) | 2007-12-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292375-A1 | Piperidinium compounds and cosmetic compositions containing them | CUTA, DPM1, TRPA1 | HPGD 2105/4885ALDH1A1 155/4885MEN1 4672/4885 |
| US-20110044923-A1 | PIPERIDINIUM COMPOUNDS AND COSMETIC COMPOSITIONS CONTAINING THEM | CUTA, DPM1, TRPA1 | HPGD 2105/4885ALDH1A1 155/4885MEN1 4672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.